Filter Results:
- Full text PDF available (126)
Publication Year
1986
2019
- This year (28)
- Last 5 years (128)
- Last 10 years (264)
Publication Type
Co-author
Journals and Conferences
Learn More
- Robert A Kyle, Morie A Gertz, +10 authors Philip R. Greipp
- Mayo Clinic proceedings
- 2003
OBJECTIVE
To determine the clinical and laboratory features of newly diagnosed multiple myeloma.
PATIENTS AND METHODS
Records of all patients in whom multiple myeloma was initially diagnosed at the… (More)
- Angela Dispenzieri, Robert A Kyle, +10 authors Morie A Gertz
- Blood
- 2003
The POEMS syndrome (coined to refer to polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes) remains poorly understood. Ambiguity exists over the features necessary to establish… (More)
- Linfeng Chen, Stephano Monti, +6 authors Margaret A Shipp
- Blood
- 2008
The role of B-cell receptor (BCR)-mediated survival signals in diffuse large B-cell lymphoma (DLBCL) remains undefined. Ligand-induced BCR signaling induces receptor oligomerization, Igalpha/beta… (More)
- Thomas E Witzig, Leo I Gordon, +10 authors Christine A. White
- Journal of clinical oncology : official journal…
- 2002
PURPOSE
Radioimmunotherapy combines biologic and radiolytic mechanisms to target and destroy tumor cells, thus offering a needed therapeutic alternative for refractory non-Hodgkin's lymphoma (NHL)… (More)
- Thomas E Witzig, Susan Michelle Geyer, +10 authors Scott H. Kaufmann
- Journal of clinical oncology : official journal…
- 2005
PURPOSE
Mantle cell lymphoma (MCL) is characterized by a t(11;14) resulting in overexpression of cyclin D1 messenger RNA. This study tested whether temsirolimus (previously known as CCI-779), an… (More)
- Thomas E Witzig, Julie Marie Vose, +10 authors Myron S. Czuczman
- Annals of oncology : official journal of the…
- 2011
BACKGROUND
Lenalidomide is an immunomodulatory agent with antitumor activity in B-cell malignancies. This phase II trial aimed to demonstrate the safety and efficacy of lenalidomide in patients with… (More)
- Arezou Khosroshahi, Zachary S. Wallace, +39 authors James Stone
- Arthritis & rheumatology
- 2015
- Mamta Aryabhushan Gupta, Jing Jing Han, +6 authors Thomas E Witzig
- Blood
- 2012
Cytokines are deregulated in cancers and can contribute to tumor growth. In patients with diffuse large-cell lymphoma (DLBCL), we observed higher levels of JAK/STAT pathway-related serum cytokines… (More)
- Angela Dispenzieri, Morie A Gertz, +11 authors Allan S. Jaffe
- Journal of clinical oncology : official journal…
- 2004
PURPOSE
Primary systemic amyloidosis (AL) is a multisystemic disorder resulting from an underlying plasma cell dyscrasia. There is no formal staging system for AL, making comparisons between studies… (More)
- Andre Goy, Rajni Sinha, +7 authors Thomas E Witzig
- Journal of clinical oncology : official journal…
- 2013
PURPOSE
Although dose-intensive strategies or high-dose therapy induction followed by autologous stem-cell transplantation have improved the outcome for patients with mantle-cell lymphoma (MCL), most… (More)